$10.37
-0.16 (-1.52%)
Enzon Pharmaceuticals, Inc. (ENZN)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

RSS Headlines
Fool UK